EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bridging Hepatitis C Care Gaps: A Modeling Approach for Achieving the WHO’s Targets in Ontario, Canada

Yeva Sahakyan iD, Aysegul Erman iD, William W L Wong, Christina Greenaway, Naveed Janjua iD, Jeffrey C Kwong iD, Beate Sander

Viruses · 2024

DOI: 10.3390/v16081224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Yeva Sahakyan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Toronto Health Economics and Technology Assessment Collaborative (THETA), University Health Network, Toronto, ON M5G 2C4, Canada. Hauptthemen laut MEDLINE: World Health Organization, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institute of Health Research (CIHR), Canada Research Chair in the Economics of Infectious Diseases held by Beate Sander.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The World Health Organization (WHO) has set hepatitis C (HCV) elimination targets for 2030. Understanding existing gaps in the “HCV care-cascade” is essential for meeting these targets. We aimed to identify the level of service scale-up needed along the “HCV care-cascade” to achieve the WHO’s HCV elimination targets in Ontario, Canada.

Methods

By employing a decision analytic model, we projected the quality-adjusted life years (QALYs) and healthcare costs for individuals with HCV in Ontario. We increased RNA testing and treatment rates to 98%, followed by increasing antibody testing uptake until we achieved the WHO’s mortality target (i.e., a 65% reduction in liver-related mortality by 2030 vs. 2015).

Results

Without scaling up by 2030, the expected QALYs and costs per person were 9.156 and CAD 48,996, respectively. Improved RNA testing and treatment rates reduced liver-related deaths to 3.3/100,000, a 57% reduction from 2015. Further doubling the antibody testing rates can achieve the WHO’s mortality target in 2035, but not in 2030. Compared to the status quo, such program would be cost-effective considering a 50,000 CAD/QALY gained threshold if annual implementation costs stayed under 2.3 M CAD/100,000 people.

Conclusions

Doubling the antibody testing rates, along with increased RNA testing and treatment rates, showed promise in meeting the WHO’s goals by 2035.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

World Health OrganizationHepatitis CHumansOntarioQuality-Adjusted Life YearsHealth Care CostsCost-Benefit AnalysisHepacivirusFemaleMaleDisease EradicationAntiviral AgentsMiddle AgedAdult

Stichwörter der Autor:innen

cost–utility analysiseconomic modelhepatitis C elimination

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Toronto Health Economics and Technology Assessment Collaborative (THETA), University Health Network, Toronto, ON M5G 2C4, Canada.
  • ICES, Toronto, ON M4N 3M5, Canada.
  • School of Pharmacy, University of Waterloo, Kitchener, ON N2G 1C5, Canada.
  • Division of Infectious Diseases, Jewish General Hospital, McGill University, Montreal, QC H3A 0G4, Canada.
  • British Columbia Centre for Disease Control (BCDC), Vancouver, BC V5Z 4R4, Canada.
  • Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.

ORCID-Profile: Yeva Sahakyan, Aysegul Erman, Naveed Janjua, Jeffrey C Kwong

Förderung

  • CIHR
  • Canadian Institute of Health Research (CIHR)
  • Canada Research Chair in the Economics of Infectious Diseases held by Beate Sander

Zitieren

APA

Sahakyan, Y., Erman, A., Wong, W. W. L., Greenaway, C., Janjua, N., Kwong, J. C., & Sander, B. (2024). Bridging Hepatitis C Care Gaps: A Modeling Approach for Achieving the WHO’s Targets in Ontario, Canada. Viruses. https://doi.org/10.3390/v16081224

Vancouver

Sahakyan Y, Erman A, Wong WWL, Greenaway C, Janjua N, Kwong JC, et al. Bridging Hepatitis C Care Gaps: A Modeling Approach for Achieving the WHO’s Targets in Ontario, Canada. Viruses. 2024. doi:10.3390/v16081224

BibTeX
@article{Sahakyan2024,
  author = {Sahakyan, Yeva and Erman, Aysegul and Wong, William W L and Greenaway, Christina and Janjua, Naveed and Kwong, Jeffrey C and Sander, Beate},
  title = {Bridging Hepatitis C Care Gaps: A Modeling Approach for Achieving the WHO’s Targets in Ontario, Canada},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16081224}
}
Kostenlos starten →